Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07780461
Recruiting Observational

Characterization and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease

NCT07780461 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2026-08-01
Last updated
2026-08-25

Condition(s) studied

PARKINSON DISEASE (Disorder)

Study summary

Parkinson's disease (PD) is a progressive neurodegenerative disorder associated with motor and non-motor impairments that affect physical function, mobility, balance, and quality of life. Although Galicia is one of the Spanish regions with a high prevalence of PD, comprehensive information regarding the functional characteristics of this population remains limited.

This observational cross-sectional study aims to characterize the sociodemographic, clinical, cognitive, behavioral, and functional profile of individuals with Parkinson's disease in Galicia and to evaluate the validity and reliability of the Short Physical Performance Battery (SPPB) in this population. The findings will provide updated information on the functional status of people with PD in Galicia and support the use of the SPPB as a practical tool for the assessment of physical performance in clinical and research settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease confirmed by a neurologist. * Provision of written informed consent by the participant or, when applicable, by a legally authorized representative. Exclusion Criteria: * Inability to complete the study assessment procedures.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Asociación de Parkinson de la Provincia de Pontevedra Pontevedra Pontevedra Recruiting
Facultad de Fisioterapia Pontevedra Pontevedra Recruiting

More University of Vigo trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07780461 on ClinicalTrials.gov ↗ ← All trials in Spain